Related Experiment Video
Updated: Dec 31, 2025

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Mixed dementia: Neglected clinical entity or nosographic artifice?
1Psychiatry Unit, Department of Health Sciences, University of Florence, Florence, Italy.
Abstract:
Clinical and pathological data show that Alzheimer's disease (AD) and vascular dementia (VaD) are the most prevalent types of dementia in the elderly. Medically speaking, mixed dementia (MxD) is a heterogenous disorder mostly referred to the coexistence of AD and VaD. The weight of vascular contribution to AD phenotype is nowadays matter of debate. Despite great efforts in the field of neurodegeneration and cerebrovascular disease, controversy over the exact nature of their relation still remains, hampering progress in the specialty and raising doubts about the MxD concept validity. Is MxD a neglected clinical entity or a nosographic artifice? Starting from the assumption that recent advances in dementia classification and diagnostic criteria make this a propitious time to set up preventive and therapeutic strategies, this narrative review and opinion paper summarizes the literature concerning the questioned etiopathogenic overlap between AD and VaD and challenges the traditional view of MxD as the mere co-occurrence of different pure forms of dementia.
Insights
Mixed dementia (MxD) involves co-occurring Alzheimer's disease (AD) and vascular dementia (VaD). This review questions if MxD is a distinct entity or simply separate conditions, advocating for a re-evaluation of its diagnostic validity.
Area of Science:
- Neurology
- Geriatrics
- Pathology
Background:
- Alzheimer's disease (AD) and vascular dementia (VaD) are leading causes of dementia in the elderly.
- Mixed dementia (MxD) is often defined as the coexistence of AD and VaD.
- The precise relationship and contribution of vascular factors to AD pathology remain debated.
Purpose of the Study:
- To review the literature on the etiopathogenic overlap between AD and VaD.
- To challenge the traditional concept of MxD as a mere aggregation of distinct pathologies.
- To discuss the validity of MxD as a clinical entity in light of recent diagnostic advancements.
Main Methods:
- Narrative review of existing literature.
- Analysis of clinical and pathological data.
- Opinion paper synthesizing current understanding and controversies.
Main Results:
- The exact nature of the relationship between AD and VaD is still debated.
- Progress in understanding neurodegeneration and cerebrovascular disease is hampered by this controversy.
- The validity of MxD as a distinct clinical entity is questioned.
Conclusions:
- Recent advances in dementia classification warrant a re-evaluation of MxD.
- The traditional view of MxD as separate co-occurring diseases may be an oversimplification.
- A new perspective on MxD is needed to develop effective preventive and therapeutic strategies.
More Related Videos
Related Concept Videos
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dissociative Amnesia
Alzheimer's Disease: Treatment
Amnesia
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
Diagnostic and Statistical Manual of Mental Disorders (DSM)

